Found: 23
Select item for more details and to access through your institution.
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 6, p. 1239, doi. 10.1111/bjh.18815
- By:
- Publication type:
- Article
Micronuclei, dmin chromosomes and MYC amplifications as a singular presentation of myeloid malignancies.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 1, p. e19, doi. 10.1111/bjh.16942
- By:
- Publication type:
- Article
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 1, p. 52, doi. 10.1111/bjh.16857
- By:
- Publication type:
- Article
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 451, doi. 10.1007/s00277-023-05582-y
- By:
- Publication type:
- Article
Maternal and fetal outcomes in pregnant women with acute promyelocytic leukemia.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 8, p. 1357, doi. 10.1007/s00277-015-2372-5
- By:
- Publication type:
- Article
Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 6, p. 947, doi. 10.1007/s00277-015-2305-3
- By:
- Publication type:
- Article
Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 1, p. 43, doi. 10.1007/s00277-013-1914-y
- By:
- Publication type:
- Article
The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2458, doi. 10.3390/cancers13102458
- By:
- Publication type:
- Article
5′‐nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate‐risk cytogenetics.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 755, doi. 10.1111/ejh.13862
- By:
- Publication type:
- Article
Ex vivo T‐cell depletion vs post‐transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft‐vs‐host disease prophylaxis for allogeneic hematopoietic stem cell transplantation.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 1, p. 114, doi. 10.1111/ejh.13529
- By:
- Publication type:
- Article
Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 138, doi. 10.1111/ejh.13417
- By:
- Publication type:
- Article
Complex measurements may be required to establish the prognostic impact of immunophenotypic markers in AML.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Complex Measurements May Be Required to Establish the Prognostic Impact of Immunophenotypic Markers in AML.
- Published in:
- American Journal of Clinical Pathology, 2015, v. 144, n. 3, p. 484, doi. 10.1309/AJCPRL6XSVFMLH9V
- By:
- Publication type:
- Article
Clinical outcomes after CPX‐351 in patients with high‐risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 14, p. 14892, doi. 10.1002/cam4.6120
- By:
- Publication type:
- Article
Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA Protocols.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 3, p. 162, doi. 10.1111/ejh.13346
- By:
- Publication type:
- Article
Herpes simplex and Epstein-Barr virus lymphadenitis in a patient with chronic lymphocytic leukemia treated with fludarabine.
- Published in:
- European Journal of Haematology, 2006, v. 77, n. 5, p. 442, doi. 10.1111/j.1600-0609.2006.00738.x
- By:
- Publication type:
- Article
Bortezomib: an effective agent in extramedullary disease in multiple myeloma.
- Published in:
- European Journal of Haematology, 2006, v. 76, n. 5, p. 405, doi. 10.1111/j.0902-4441.2005.t01-1-EJH2462.x
- By:
- Publication type:
- Article
Glasdegib with LDAC in Newly Diagnosed Patients with Acute Myeloid Leukemia (AML) Unsuitable for Intensive Chemotherapy: Effects on Transfusions and Marrow Recovery vs LDAC Alone.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S230, doi. 10.1016/j.clml.2019.07.114
- By:
- Publication type:
- Article
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
- By:
- Publication type:
- Article
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
- By:
- Publication type:
- Article
First‐in‐human study of JNJ‐63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 3, p. 429, doi. 10.1111/cts.13467
- By:
- Publication type:
- Article
Bortezomib-Induced Rhabdomyolysis in Multiple Myeloma.
- Published in:
- Acta Haematologica, 2006, v. 116, n. 3, p. 203, doi. 10.1159/000094682
- By:
- Publication type:
- Article
A phase 3 trial of azacitidine versus a semi‐intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 12, p. 2003, doi. 10.1002/cncr.33403
- By:
- Publication type:
- Article